Technical analysis of Anika Therapeutics, Inc. (ANIK): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies.
Price Performance
| 1 month | -2.69% |
| 3 months | +45.56% |
| Year-to-date | +118.42% |
| 1 year | +142.38% |
| 3 years | +23.62% |
52-Week Range
| 52-week High | $22.88 |
| 52-week Low | $8.64 |
| Avg Volume (90d) | 88K |
Technical Indicators
| SMA 50 | $19.26 |
| SMA 200 | $14.39 |
| Beta | 0.28 |
| 30-day Volatility (annualised) | 36.8% |
| Price vs SMA 50 | +9.0% |
| Price vs SMA 200 | +45.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $9.75 | |
| 2025-11 | $9.88 | +1.3% |
| 2025-12 | $9.61 | -2.7% |
| 2026-01 | $9.23 | -4.0% |
| 2026-02 | $14.36 | +55.6% |
| 2026-03 | $14.50 | +1.0% |
| 2026-04 | $12.45 | -14.1% |
| 2026-05 | $14.53 | +16.7% |
| 2026-06 | $14.63 | +0.7% |
| 2026-07 | $19.28 | +31.8% |
| 2026-08 | $20.87 | +8.2% |
| 2026-09 | $20.99 | +0.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | $42M |
| 2026-09-15 | $0.04 | $67M |
| 2026-09-15 | | $71M |
| 2026-09-15 | | |
| 2026-09-15 | $0.13 | $458M |
| 2026-09-15 | | |
Price
| Price | $21.03 |
| Market Cap | $281M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 2.02 |
| EV / EBITDA | 97.19 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.17 |
| Current Ratio | 4.48 |